PT762895E - Vacina sintetica para proteccao contra a infeccao de virus da imunodeficiencia humana - Google Patents
Vacina sintetica para proteccao contra a infeccao de virus da imunodeficiencia humanaInfo
- Publication number
- PT762895E PT762895E PT95917797T PT95917797T PT762895E PT 762895 E PT762895 E PT 762895E PT 95917797 T PT95917797 T PT 95917797T PT 95917797 T PT95917797 T PT 95917797T PT 762895 E PT762895 E PT 762895E
- Authority
- PT
- Portugal
- Prior art keywords
- protection against
- human immunodeficiency
- against infection
- immunodeficiency viruses
- synthetic vaccine
- Prior art date
Links
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 229940126577 synthetic vaccine Drugs 0.000 title 1
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23530594A | 1994-04-29 | 1994-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT762895E true PT762895E (pt) | 2002-11-29 |
Family
ID=22884945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95917797T PT762895E (pt) | 1994-04-29 | 1995-04-28 | Vacina sintetica para proteccao contra a infeccao de virus da imunodeficiencia humana |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0762895B1 (pt) |
| JP (1) | JPH09512561A (pt) |
| AT (1) | ATE221786T1 (pt) |
| AU (1) | AU707894B2 (pt) |
| CA (1) | CA2189045A1 (pt) |
| DE (1) | DE69527708T2 (pt) |
| DK (1) | DK0762895T3 (pt) |
| ES (1) | ES2177648T3 (pt) |
| PT (1) | PT762895E (pt) |
| WO (1) | WO1995029700A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7465696A (en) * | 1995-10-20 | 1997-05-07 | Duke University | Synthetic vaccine for protection against human immunodeficiency virus infection |
| AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| HUP0201220A3 (en) | 1999-05-13 | 2004-07-28 | Wyeth Holdings Corp Madison | Adjuvant combination formulations |
| JP2004503205A (ja) | 2000-02-04 | 2004-02-05 | デューク・ユニバーシティー | ヒト免疫不全ウイルスワクチン |
| US7033593B2 (en) | 2000-09-22 | 2006-04-25 | Duke University | Immunogen comprising an HIV envelope protein, a ligand and H2 peptide |
| WO2002024149A2 (en) | 2000-09-22 | 2002-03-28 | Duke University | Immunogen comprising ligand bound hiv envelpe protein |
| WO2003004620A2 (en) | 2001-07-05 | 2003-01-16 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| US7195768B2 (en) | 2001-11-07 | 2007-03-27 | Duke University | Polyvalent immunogen |
| US7172761B2 (en) | 2001-11-07 | 2007-02-06 | Duke University | Polyvalent immunogen |
| EP1461077A4 (en) | 2001-11-07 | 2006-01-25 | Univ Duke | POLYVALENT IMMUNOGEN |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013548A (en) * | 1987-09-08 | 1991-05-07 | Duke University | Production of antibodies to HIV |
| US5019387A (en) * | 1987-09-08 | 1991-05-28 | Duke University | Production of antibodies to HIV |
-
1995
- 1995-04-28 AT AT95917797T patent/ATE221786T1/de not_active IP Right Cessation
- 1995-04-28 EP EP95917797A patent/EP0762895B1/en not_active Expired - Lifetime
- 1995-04-28 WO PCT/US1995/005465 patent/WO1995029700A1/en active IP Right Grant
- 1995-04-28 CA CA002189045A patent/CA2189045A1/en not_active Abandoned
- 1995-04-28 AU AU23726/95A patent/AU707894B2/en not_active Ceased
- 1995-04-28 PT PT95917797T patent/PT762895E/pt unknown
- 1995-04-28 ES ES95917797T patent/ES2177648T3/es not_active Expired - Lifetime
- 1995-04-28 DK DK95917797T patent/DK0762895T3/da active
- 1995-04-28 DE DE69527708T patent/DE69527708T2/de not_active Expired - Fee Related
- 1995-04-28 JP JP7528495A patent/JPH09512561A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2372695A (en) | 1995-11-29 |
| EP0762895A4 (en) | 1997-08-27 |
| DK0762895T3 (da) | 2002-09-02 |
| EP0762895B1 (en) | 2002-08-07 |
| CA2189045A1 (en) | 1995-11-09 |
| ATE221786T1 (de) | 2002-08-15 |
| DE69527708T2 (de) | 2003-04-30 |
| EP0762895A1 (en) | 1997-03-19 |
| DE69527708D1 (de) | 2002-09-12 |
| ES2177648T3 (es) | 2002-12-16 |
| AU707894B2 (en) | 1999-07-22 |
| WO1995029700A1 (en) | 1995-11-09 |
| JPH09512561A (ja) | 1997-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4474757A (en) | Synthetic vaccine and process for producing same | |
| EE9900343A (et) | Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon | |
| DK0538437T3 (da) | Immunstimulerende og immunforstærkende, rekonstituerede influenzavirosomer og vacciner indeholdende dem | |
| PT762895E (pt) | Vacina sintetica para proteccao contra a infeccao de virus da imunodeficiencia humana | |
| DE68927348D1 (de) | Künstlicher impfstoff gegen aids-virus | |
| DE69632235D1 (de) | Newcastle-Krankheitsvirus-Kombinationsimpfstoff | |
| BR9712970A (pt) | Método para produção de vacina para proteção contra virus sincitial respiratório, mistura de proteìna de fusão purificada, composição imunogênica | |
| CY1105010T1 (el) | Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου | |
| EP0225066A3 (en) | Antigen determinant peptides and a process for the preparation thereof | |
| Macfarlan et al. | Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain | |
| ES2127294T3 (es) | Vacunas del virus de la inmunodeficiencia anti-felino (fiv). | |
| DE68925660D1 (de) | Peptidfragmente von HIV | |
| PT838222E (pt) | Composicoes de vacina compreendendo imunogenios inactivados e virus da anemia dagalinha (cav) vivos | |
| BR9202575A (pt) | Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose | |
| KR920004422A (ko) | Hiv의 주요 중화 결정인자 | |
| EP0289110A3 (en) | Conjugate malaria vaccine | |
| CA2100591A1 (en) | Avirulent anti-rabies vaccine | |
| DK1149167T3 (da) | Virusvaccine | |
| IE873268L (en) | Conjugate vaccine | |
| CO5300406A1 (es) | Vacuna | |
| RU94040393A (ru) | Синтетические пептиды для вакцины против краснухи | |
| AR241713A1 (es) | Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe. | |
| KR910011897A (ko) | 말라리아 백신 | |
| CY1105176T1 (el) | Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας | |
| AP9901615A0 (en) | Multiple branch peptide constructions. |